Blue Owl Capital Inc. has agreed to acquire Sila Realty Trust, Inc. for approximately $2.4 billion, adding Sila’s 137 net‑lease healthcare properties—more than 5 million square feet—to Blue Owl’s portfolio. Newmark Group, Inc. is serving as the strategic advisor for the transaction, a role that underscores its expertise in structuring large, complex real‑estate deals.
The deal is driven by Blue Owl’s strategy to deepen its exposure to the resilient healthcare lease market. Sila’s properties are concentrated in high‑growth U.S. markets and are anchored by leading healthcare systems, providing Blue Owl with a stable, long‑duration income stream. The purchase price of $30.38 per share represents a 19.0% premium to Sila’s closing stock price on April 17, 2026, and a 25.6% premium to the 30‑day volume‑weighted average price, reflecting the market’s confidence in the portfolio’s quality and the strategic fit for Blue Owl.
Newmark’s advisory role is a key element of the transaction. The firm’s recent work—such as arranging a $1.65 billion refinancing for One Madison Avenue and securing a 4.2 million‑square‑foot leasing assignment in Suburban Philadelphia—demonstrates its capability to manage high‑profile real‑estate transactions. By advising on this deal, Newmark positions itself to capture future fee opportunities in the healthcare net‑lease space and signals its continued focus on high‑value, recurring‑revenue mandates.
Market reaction to the announcement was mixed. Sila’s shares rose 19.2% to $30.43 on April 20, 2026, driven by the premium offered and the expectation of immediate realized benefit for shareholders. Blue Owl’s shares remained flat, indicating that investors viewed the acquisition as a neutral event for the company’s short‑term outlook. Newmark’s shares also showed a muted response, reflecting the market’s focus on fee generation rather than immediate earnings impact.
"I am extremely proud of the company that we have built at Sila Realty Trust. Our success in curating a portfolio of high‑quality net lease healthcare properties is a testament to the vision, skill, dedication, and culture to which all my colleagues have contributed," said Michael A. Seton, President and CEO of Sila Realty Trust. "The consummation of this transaction will provide significant and immediate realized benefit to our shareholders." "This transaction provides us with a compelling opportunity to acquire a scaled portfolio with durable cash flows and attractive long‑term growth characteristics, while further expanding Blue Owl managed funds' exposure to an asset class and sector we view as both resilient and essential given its critical role in both society and the economy," said Marc Zahr, Co‑President and Global Head of Real Assets at Blue Owl.
The acquisition will transition Sila from a publicly traded REIT to a private company, ending its NYSE listing. Blue Owl, which manages over $307 billion in assets, will now own a portfolio that enhances its healthcare exposure and provides a predictable income stream. For Newmark, the advisory fee from this transaction is expected to contribute to its recurring‑revenue pipeline and reinforce its reputation as a go‑to advisor for large, sector‑specific real‑estate deals.
The deal is projected to close in the second or third quarter of 2026, subject to shareholder and regulatory approvals. The transaction represents a significant expansion of Blue Owl’s portfolio and highlights Newmark’s continued involvement in high‑value, sector‑specific real‑estate deals, reinforcing its competitive position in the commercial real‑estate services market.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.